UK markets closed

Kuros Biosciences AG (KURN.SW)

Swiss - Swiss Delayed price. Currency in CHF
Add to watchlist
6.53+0.05 (+0.77%)
At close: 05:30PM CEST
Currency in CHF

Valuation measures4

Market cap (intra-day) 238.97M
Enterprise value 227.25M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.06
Price/book (mrq)4.21
Enterprise value/revenue 6.77
Enterprise value/EBITDA -21.83

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3369.57%
S&P500 52-week change 323.57%
52-week high 38.40
52-week low 31.25
50-day moving average 36.06
200-day moving average 33.97

Share statistics

Avg vol (3-month) 3219.01k
Avg vol (10-day) 3267.97k
Shares outstanding 536.88M
Implied shares outstanding 636.88M
Float 824.55M
% held by insiders 135.24%
% held by institutions 17.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 308 Oct 2020
Ex-dividend date 4N/A
Last split factor 21:100
Last split date 323 Jun 2016

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -40.90%
Operating margin (ttm)-19.94%

Management effectiveness

Return on assets (ttm)-7.01%
Return on equity (ttm)-21.86%

Income statement

Revenue (ttm)33.56M
Revenue per share (ttm)0.92
Quarterly revenue growth (yoy)173.80%
Gross profit (ttm)N/A
EBITDA -6.56M
Net income avi to common (ttm)-13.73M
Diluted EPS (ttm)-0.38
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)14.21M
Total cash per share (mrq)0.39
Total debt (mrq)2.21M
Total debt/equity (mrq)3.90%
Current ratio (mrq)2.06
Book value per share (mrq)1.54

Cash flow statement

Operating cash flow (ttm)-8.84M
Levered free cash flow (ttm)-7.29M